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Naturally arising regulatory T (Treg) cells express the
transcription factor FoxP3, which critically controls
the development and function of Treg cells. FoxP3
interacts with another transcription factor Runx1
(also known as AML1). Here, we showed that Treg
cell-specific deficiency of Cbfb, a cofactor for all
Runx proteins, or that of Runx1, but not Runx3,
induced lymphoproliferation, autoimmune disease,
and hyperproduction of IgE. Cbfb-deleted Treg cells
exhibited impaired suppressive function in vitro and
in vivo, with altered gene expression profiles
including attenuated expression of FoxP3 and high
expressionof interleukin-4. TheRunxcomplexbound
tomore than 3000gene loci in Tregcells, including the
Foxp3 regulatory regions and the Il4 silencer. In
addition, knockdown of RUNX1 showed that RUNX1
is required for the optimal regulation of FoxP3
expression in human T cells. Taken together, our
results indicate that the Runx1-Cbfb heterodimer is
indispensable for in vivo Treg cell function, in partic-
ular, suppressive activity and optimal expression of
FoxP3.
INTRODUCTION
CD4+CD25+FoxP3+ naturally occurring regulatory T (Treg) cells
play essential roles for the maintenance of immunological self-
tolerance and immune homeostasis by actively suppressing
aberrant or excessive immune responses harmful to the host
(Sakaguchi et al., 2006). Natural Treg cells specifically express
the transcription factor FoxP3, which critically controls the devel-
opment and the function of Treg cells as illustrated by FOXP3
mutations (Ochs et al., 2005). FoxP3 deficiency or dysfunction
in humans results in the development of IPEX (immune dysregu-
lation, polyendocrinopathy, enteropathy, X-linked) syndrome,which is characterized by severe autoimmune disease, allergy,
and inflammatory bowel disease (Sakaguchi et al., 2006).
FoxP3 expression can confer suppressive activity to Treg cells,
suppress the production of cytokines such as interleukin-2
(IL-2) and interferon-gamma (IFN-g), and upregulate the expres-
sion of Treg cell-associated molecules including CD25 and cyto-
toxic T lymphocyte-associated antigen 4 (CTLA-4) (Fontenot
et al., 2003; Hori et al., 2003; Khattri et al., 2003). Recent studies
have shown that the gene regulatory function of FoxP3 requires
its association with other transcription factors, such as NFAT
(nuclear factor of activated T cells), NF-kB (nuclear factor-kB),
and Runx1 (runt-related transcription factor 1), also known as
AML1 (acute myeloid leukemia 1), and with histone deacetylases
and acetyltransferases (Bettelli et al., 2005; Li et al., 2007; Ono
et al., 2007; Wu et al., 2006). Yet, the precise molecular mecha-
nisms by which FoxP3 controls Treg cell function remain to be
elucidated.
The Runx (AML) transcription factors consist of three
members: Runx1 (AML1), Runx2 (AML3), and Runx3 (AML2)
(van Wijnen et al., 2004). All Runx proteins bind to the specific
DNA consensus sequences (ACCACA) via a highly conserved
DNA-binding runt domain. Runx binding is stabilized by the asso-
ciation with Cbfb (core-binding factor b), a non-DNA-binding
cofactor essential for the function of all Runx proteins (Speck,
2001). The Runx-Cbfb heterodimeric complex interacts with
other DNA-binding transcription factors, coactivators, or core-
pressors to either activate or repress expression of the target
genes in a context-dependent manner (Durst and Hiebert,
2004; Taniuchi and Littman, 2004). In addition to the essential
requirement of Runx proteins for definitive hematopoiesis (de
Bruijn and Speck, 2004), Runx1 and Runx3 are crucially involved
in the differentiation and function of peripheral T cells (Djuretic
et al., 2007; Komine et al., 2003; Naoe et al., 2007; Zhang et al.,
2008) as well as thymic T cell development (Grueter et al., 2005;
Sato et al., 2005; Setoguchi et al., 2008; Taniuchi et al., 2002;
Woolf et al., 2003). We have previously shown that Runx1 binds
to the promoter of the Il2 and Ifng genes and upregulates the
production of IL-2 and IFN-g, respectively. Further, FoxP3 binds
to Runx1 in Treg cells, thereby repressing Il2 and Ifng andImmunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc. 609
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(Ono et al., 2007). We have also shown that, in vitro, FoxP3 can
interact with the other members of the Runx family, Runx2 and
Runx3, in addition to Runx1 (Ono et al., 2007). These findings
collectively suggest that the Runx-dependent transcription
program operating in conventional T cells could be modulated
in Treg cells through interaction with FoxP3. Yet, it remains
obscure whether the Runx-mediated gene regulation is indeed
required for the in vivo function of Treg cells.
In this report, we have generated mice with Treg cell-specific
conditional deletion ofCbfb to analyze in vivo the possible contri-
bution of Runx-dependent gene regulation to Treg cell function
because all Runx proteins need to form a heterodimeric complex
with Cbfb for exerting transcriptinal activities and Cbfb defi-
ciency disrupts the function of the Runx complex (Speck,
2001). Here, we showed that Treg cell-specific Cbfb-deficient
mice spontaneously developed lymphoproliferation, autoim-
mune disease, and IgE hyperproduction and that Cbfb-deleted
Treg cells exhibited impaired suppressive activity both in vitro
and in vivo. In addition, Treg cell-specific conditional deletion
of Runx1, but not Runx3, led to the development of immunolog-
ical diseases similar to those observed in Treg cell-specific Cbfb
deficiency. Our findings thus indicate that the heterodimeric
Runx1-Cbfb complex is an indispensable transcription regulator
for in vivo functions of Treg cells and that it is a potential thera-
peutic target for controlling physiological and pathological
immune responses.
RESULTS
Treg Cell-Specific Deletion of Cbfb and the Resulting
Development of Autoimmune Disease
To determine whether Runx proteins were required for in vivo
function of FoxP3+ Treg cells, we generated Treg cell-specific
Cbfb-deleted mice by crossing mice harboring LoxP-flanked
Cbfb allele with Foxp3-Ires-Cre (FIC) knockin mice, which faith-
fully express Cre recombinase in FoxP3+ T cells (Naoe et al.,
2007; Wing et al., 2008). FIC-mediated genomic deletion of
LoxP-flanked region occurred in almost 100%CD4+FoxP3+ cells
and a small population of CD8+ T cells (Wing et al., 2008). With
genomic DNA-PCR analyses of subpopulations of thymocytes
and splenic T cells from CbfbF/F: FIC mice, inactivation of the
Cbfb gene was initiated specifically in CD4-single positive
(CD4SP) HSAloCD25hi mature thymocytes and was completed
in CD4+CD25hi splenic T cells, indicating Treg cell-specific dele-
tion of the Cbfb gene (Figure 1A, left). Some of the CD4+CD25
T cells also harbored the genomic Cbfb deletion (Figure 1A,
left). This can be attributed to the presence of CD4+CD25-FoxP3+
Treg cells in this CD4+CD25 population (Figure S1 and Supple-
mental Data available online). As a consequence of the gene
inactivation, the Cbfb protein was undetectable in CD4+CD25hi
splenocytes, although a substantial amount of the Cbfb protein
remained in CD4SP HSAloCD25hi thymocytes (Figure 1A, right).
Thus, theCbfbprotein is gradually decreased inFoxP3+cells after
Cbfb gene deletion in the thymus and almost completely lost in
theperiphery,which is consistentwitha similar findingwithcondi-
tional Cbfb deletion by Cd4-Cre transgene (Naoe et al., 2007).
Notably, CbfbF/F: FIC mice spontaneously developed severe
lymphadenopathy and splenomegalywith significantly increased610 Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc.numbers of splenocytes by 14 weeks of age (Figure 1B). Various
types of immune cells including CD4+ T cells, CD8+ T cells, B
cells, macrophages, and dendritic cells increased in the enlarged
spleens of CbfbF/F: FIC mice (Figure S2). Seventy percent of
CbfbF/F: FIC mice developed histologically evident gastritis
accompanying high titers of anti-gastric parietal cell autoanti-
bodies in the sera, whereas control CbfbF/+: FIC littermates did
not (Figures 1C and 1D). Flow cytometric analysis revealed that
non-Treg T cells, i.e., CD4+FoxP3 conventional T cells and
CD8+ T cells, in CbfbF/F: FIC mice showed an activated or
memory phenotype; e.g., CD69+, CD122+, CD44hi, and CD62Llo
(Figure 1E). CD4+ and CD8+ T cells abundantly produced
cytokines such as IFN-g, IL-2, IL-4, and IL-10, as revealed by
intracellular cytokine staining after stimulation with PMA and
ionomycin (Figure 1F). In addition, CbfbF/F: FIC mice showed
10-fold elevated concentrations of serum IgE and 1.5-fold
increase in serum IgG (Figure 1G). Thus, Treg cell-specific Cbfb
deficiency produced autoimmune disease and led to hyperpro-
duction of IgE.
The Effects of Treg Cell-Specific Cbfb Gene Deletion
on Treg Cell Development and Function
To analyze the mechanism of autoimmunity caused by Treg cell-
specific Cbfb deficiency, we attempted to determine whether
thymic generation and differentiation of Treg cells, their periph-
eral survival, or their suppressive function was affected by the
deficiency.
There was no significant difference in the number of total or
FoxP3+ thymocytes between CbfbF/F: FIC and CbfbF/+: FIC
mice (Figure 2A and Figure S3). HSAloCD25hiFoxP3+CD4SP
thymic Treg cells normally developed in CbfbF/F: FIC mice as in
control CbfbF/+: FIC mice (Figure 2B). Whereas Runx proteins
were required for the differentiation of immature thymocytes
to TCRbhiHSAloCD4SP mature thymocytes (Egawa et al.,
2007), the generation of FoxP3+TCRbhiHSAloCD4SP mature
thymocytes was not markedly impaired in CbfbF/F: FIC mice
(Figure S4). Residual Cbfb protein might be sufficient to support
differentiation and maturation of FoxP3+ cells in the thymus
(Figure 1A).
We next examined whether Treg cell homeostasis was
impaired in the periphery of Cbfb-deleted mice. The proportion
of CD4+FoxP3+ Treg cells to total CD4+ T cells and the absolute
number of Treg cells were slightly higher in CbfbF/F: FIC mice
than inCbfbF/+: FICmice (Figures 2C and 2D). Notably, Treg cells
inCbfbF/F: FICmice showed substantially decreased expression
of FoxP3, compared to those in control mice (Figure 2D). Expres-
sion of Ki-67, a cellular marker for proliferation, indicated that
an equivalent or larger proportion of Treg cells were active in
cell cycle in CbfbF/F: FIC mice compared with control mice
(Figure 2E). In CbfbF/F: FIC mice, Ki-67 resting Treg cells
showed reduced expression of FoxP3, whereas Ki-67hi prolifer-
ating Treg cells expressed FoxP3 at equivalent amounts as
Ki-67hi Treg cells in control mice (Figure 2E). In vivo BrdU labeling
also revealed that CD4+CD25hi splenocytes in CbfbF/F: FICmice
were more actively proliferating than those in CbfbF/+: FIC mice
(Figure 2F). Treg cells in the former expressed only slightly lower
amounts of CD127 (IL-7 receptor a chain) andwere not apoptotic
according to 7-AAD (7-amino-actinomycin D) and Annexin V
staining, in accord with the previous finding that Runx1-deficient
Immunity
Roles of Runx Complexes for Treg Cell FunctionTreg cells in Runx1F/F: Cd4-Cre mice were apoptosis resistant
(Egawa et al., 2007) (Figures 2G and 2H).
Phenotypically, Cbfb-deleted Treg cells expressed CD25 and
glucocorticoid-induced tumor necrosis factor receptor family-
related protein (GITR) at higher amounts and CTLA-4 at equiva-
lent amounts compared to control Treg cells, whereas they
scarcely expressed CD103 in accord with the finding that Runx3
controls CD103 expression (Grueter et al., 2005) (Figure 3A).
Neither Cbfb-deleted nor control Treg cells proliferated in
response to in vitro polyclonal TCR stimulation with anti-CD3
(Figure 3B). Yet, Cbfb-deleted Treg cells were less suppressive
in vitro (Figure 3C). In addition, they failed to prevent the develop-
ment of colitis and weight loss in SCID mice when cotransferred
with BALB/c CD4+CD25CD45RBhi T cells, in contrast to effec-
tive disease prevention by cotransfer of control Treg cells (Fig-
ures 3D–3F). Similarly,Cbfb-deleted Treg cells failed to suppress
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Figure 1. TregCell-SpecificCbfbDeficiency
Induced Autoimmune Disease and Hyper-
production of IgE
(A) Treg cell-specific Cbfb deletion in CbfbF/F: FIC
mice. PCR analysis (left) for detecting CbfbF (flox)
and Cbfb-deleted (del.) alleles of the Cbfb gene
was performed with genomic DNA from indicated
thymocyte (top) and splenocyte (bottom) subpop-
ulations of CbfbF/F: FIC mice as templates. Immu-
noblot analysis (right) of Cbfb protein expression
in indicated thymocyte (top) and splenocyte
(bottom) subpopulations of CbfbF/F: FIC and
control CbfbF/+: FIC littermates is shown. Results
representative of two experiments are shown.
(B) The absolute numbers of total splenocytes are
shown as the mean ± SD value from CbfbF/F: FIC
mice and CbfbF/+: FIC littermates (n = 4) at 2 and
14 weeks of age. *p = 0.02.
(C) Hematoxylin and eosin staining of sections
from stomachs of 7- to 8-week-old CbfbF/F: FIC
and CbfbF/+: FIC littermates (n = 10). Representa-
tive photomicrographs are shown. Scale bars
represent 10.0 mm.
(D) Titers of parietal cell autoantibodies in the sera
of 8-week-old CbfbF/F: FIC and CbfbF/+: FIC
littermates (n = 10) were assessed by ELISA. Hori-
zontal lines represent averages from each group.
**p = 0.01.
(E) Activated surface-marker phenotype of
CD4+FoxP3 conventional T cells and CD8+
T cells in CbfbF/F: FIC mice at 16 weeks of age.
Data are representative of five experiments.
(F) Production of proinflammatory cytokines by
CD4+ and CD8+ T cells in CbfbF/F: FIC mice at
14 weeks of age. Data are representative of three
experiments.
(G) Titers of IgG and IgE in the sera of 8-week-old
CbfbF/F: FIC and CbfbF/+: FIC littermates (n = 10)
were assessed by ELISA. Horizontal lines represent
averages fromeachgroup. ***p=0.04; ****p=0.001.
the development of gastritis (data not
shown). Cbfb-deleted Treg cells survived
when transferred to SCID mice (Fig-
ure S5A), indicating that the impaired
in vivo suppressive activity of Cbfb-
deleted Treg cells was not due to their shorter survival. In addi-
tion, the attenuated CD103 expression in Cbfb-deleted Treg
cells (Figure S5B) would not be responsible for the impaired
Treg cell function because others reported that Treg cell-medi-
ated control of colitis did not require CD103 expression by
Treg cells (Annacker et al., 2005).
Collectively, these findings indicate that failure in Treg cell-
mediated self-tolerance inCbfbF/F: FICmice is not due to numer-
ical deficiency, reduced proliferation, or enhanced apoptosis of
FoxP3+ Treg cells, but due to their impaired suppressive activity.
Cbfb-Deleted Treg Cells Show Hyperproduction of IL-4
Treg cells hardly produce cytokines such as IL-2, IFN-g, and IL-4
(Sakaguchi et al., 2006). Flow cytometric analysis revealed that
a larger proportion of FoxP3+ Treg cells from CbfbF/F: FIC mice
produced IL-4 and IL-10 compared to Treg cells from controlImmunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc. 611
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Figure 2. Generation and Homeostasis of
Treg Cells in CbfbF/F: FIC Mice
(A) The absolute numbers of FoxP3+ thymocytes
from 2-week-old CbfbF/F: FIC and CbfbF/+: FIC
littermates (n = 3) are shown as the mean ± SD
value.
(B) Expression of CD25 and FoxP3 by CD4SP
HSAlo thymocytes from 3-week-old CbfbF/F: FIC
and CbfbF/+: FIC littermates. Results representa-
tive of three experiments are shown.
(C) The absolute numbers of CD4+FoxP3+ spleno-
cytes from CbfbF/F: FIC and CbfbF/+: FIC litter-
mates (n = 3) at 2 weeks and 3 months of age are
shown as the mean ± SD value. *p = 0.05.
(D) Expression of FoxP3 by CD4+ splenocytes from
7-week-old CbfbF/F: FIC and CbfbF/+: FIC litter-
mates. Results representative of five experiments
are shown.
(E) Expression of Ki-67 and FoxP3 by CD4+ T cells
from 7-week-old CbfbF/F: FIC and CbfbF/+: FIC
littermates. Data are representative of three
experiments.
(F) 9-week-old CbfbF/F: FIC and CbfbF/+: FIC litter-
mates were injected with BrdU for 3 days, and
incorporation of BrdU into CD4+CD25hi spleno-
cytes was assessed by flow cytometry. Results
representative of four experiments are shown.
(G) Expression of CD127 and FoxP3 by CD4+
T cells from 7-week-old CbfbF/F: FIC and CbfbF/+:
FIC littermates. Results representative of four
experiments are shown.
(H) 7-AAD and AnnexinV staining of CD4+CD25hi
cells from 8-week-old CbfbF/F: FIC and littermate
control mice. Results representative of two exper-
iments are shown.mice, whereas there were no substantial differences in the
percentage of IL-2- or IFN-g-producing cells among FoxP3+
Treg cells (Figure 3G). Few IL-17-expressing FoxP3+ Treg
cells were present in both groups of mice (Figure 3G). The
amount of mRNA for each cytokine in CD4+CD25hi cells in
CbfbF/F: FIC and control mice correlated with the protein
expression. However, mRNA for IL-17, which was detectable
in CbfbF/+: FIC mice, was substantially lower in CbfbF/F: FIC
mice (Figure 3H).
Next, the expression of transcription factors Foxp3, Tbx21,
Gata3, and Rorgt, all of which are essential for Th or Treg cell
lineage differentiation, were examined in Cbfb-deleted Treg
cells. Foxp3 mRNA expression decreased in Cbfb-deleted
Treg cells, which is consistent with decreased FoxP3 expression
at the protein level (Figure S6). In contrast to the hyperproduction
of Th2 cell cytokines IL-4 and IL-10, mRNA expression of Th2
cell-specific transcription factorGata3 inCbfb-deleted Treg cells
was equivalent to that in control Treg cells, whereas Cbfb-
deleted Treg cells showed higher expression of Th1 cell-specific
transcription factor Tbx21. Thus, hyperproduction of Th2 cell
cytokines byCbfb-deleted Treg cells was not due to overexpres-
sion of Gata3, although it has been reported that Runx1
represses Gata3 expression in conventional CD4+ T cells
(Komine et al., 2003). The expression of Rorgt, which controls
the differentiation of IL-17-producing Th17 cells, also decreased
in Cbfb-deleted Treg cells compared with control Treg cells
(Figure S6). Taken together, our findings show that Cbfb-defi-612 Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc.cient Treg cells transcribed Il17a and Rorgt to lesser extents
than control Treg cells, whereas Il4, Il10, and Tbx21 were more
actively transcribed in the former.
Genes Possibly Associated with Impaired Suppressive
Function of Cbfb-Deleted Treg Cells
To elucidate the molecular mechanisms underlying the dysfunc-
tion of Cbfb-deleted Treg cells, we examined gene expression
profiles of CD4+CD25hi cells from CbfbF/F: FIC and littermate
CbfbF/+: FIC mice by expression microarray. We first focused
on the previously described ‘‘Treg cell signature’’ genes, which
are differentially expressed between Treg cells and conventional
CD4+ T cells and therefore thought to be closely related to Treg
cell-intrinsic properties including suppressive function (Hill
et al., 2007). Sixty-nine signature genes including Socs2 and
Nrp1 were found to be differentially expressed in Cbfb-deleted
Treg cells (unpaired t test, p < 0.05. see Table S1). Yet, there
were not significant differences in the expression of many well-
known Treg cell-associated genes, such as Ctla4, Tnfrsf18
(Gitr), Gzmb, Folr4, and Gpr83, between Cbfb-deleted and
control Treg cells (Figure 4A). Decreased mRNA expression of
Itgae (CD103) in Cbfb-deleted Treg cells was consistent with
the aforementioned flow cytometry results (Figure 4A and
Figure 3A). Using the false discovery rate (FDR)-controlling
procedure (FDR < 0.2), we further attempted to determine other
genes that were differentially expressed in Cbfb-deleted Treg
cells. We found that 22 and 24 genes were significantly up- or
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Figure 3. Impaired In Vivo- and In Vitro-Suppressive Activity of Cbfb-Deleted Treg Cells
(A) Expression of FoxP3 and other Treg cell-associated molecules by CD4+ T cells from 7-week-old CbfbF/F: FIC and CbfbF/+: FIC littermates. Results represen-
tative of at least three experiments are shown.
(B) CD4+CD25 conventional T cells fromwild-type BALB/cmice and CD4+CD25hi cells fromCbfbF/F: FIC andCbfbF/+: FIC littermates were stimulated in vitro for
3 days, and cell proliferation was assessed by thymidine incorporation. Data are mean ± SD of triplicates done in one experiment representative of seven.
(C) In vitro suppression assay with CD4+CD25 T cells from 6-week-old wild-type BALB/c mice as responders and CD4+CD25hi T cells from 5-week-oldCbfbF/F:
FIC (red lines) or CbfbF/+: FIC (blue lines) littermates as suppressors. Data are mean ± SD of triplicates done in one experiment representative of four. *p = 0.004
(unpaired t test).
(D) Eight-week-old C.B-17 SCIDmice received 43 105 CD4+CD25CD45RBhi cells purified fromwild-type BALB/cmice either alone (black lines) or together with
33 105 CD4+CD25hi cells purified from 6-week-oldCbfbF/F: FIC (red lines) orCbfbF/+: FIC (blue lines) littermates. Bodyweight is represented as the percentage of
initial weight (mean ± SD). Results from a total of four independent experiments are shown. **p = 0.01; ***p = 0.02, CbfbF/F: FIC versus CbfbF/+: FIC by Mann-
Whitney U test.
(E) Hematoxylin and eosin staining of sections from colons of SCIDmice transferred as described in (D) (n = 3 each group). Representative photomicrographs are
shown. Scale bars represent 10.0 mm.
(F) Colitis were histologically scored (n = 3 each group).
(G) Costaining of FoxP3 and the indicated cytokines in CD4+ T cells from 14-week-old CbfbF/F: FIC and CbfbF/+: FIC littermates fter the stimulation with PMA and
ionomycin for 6 hr. Results representative of three experiments are shown.
(H) Relative mRNA expression of the indicated cytokines in CD4+CD25hi cells purified from CbfbF/F: FIC and CbfbF/+: FIC littermates at 6 weeks of age. Data are
representative of two experiments.Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc. 613
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Roles of Runx Complexes for Treg Cell Functiondownregulated, respectively, in Cbfb-deleted Treg cells (Fig-
ure 4B and Table S2). Differentially expressed molecules
included IL-4, CCR5, leukotriene B4 receptor 1 (Ltb4r1, also
called BLT1), and CD160, which are secreted or have extracel-
lular regions possibly involved in cellular interactions.
The Runx Complex Binds to the Regulatory Regions
of Many Genes Including Foxp3 and Il4
To further investigate Runx-dependent gene regulation in Treg
cells, we attempted to identify target genes of the Runx complex.
Genome-wide analysis with chromatin immunoprecipitation
(ChIP) coupled with promoter tiling array showed that the Runx
complex bound to the promoter regions of 3566 genes including
Foxp3 (Figure 5A and Table S3). Similar analysis with the custom-
ized array covering the Foxp3 gene locus revealed that the Runx
complex bound to several regions of the Foxp3 gene in Treg cells
prepared from wild-type BALB/c mice (Figure 5B, left). It has
been reported that the following three conserved noncoding
sequences (CNSs) contribute to Foxp3 expression: one CNS
located in 0.5 kb upstream of the transcription start site (CNS1)
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Figure 4. Gene Expression Analysis of Treg
Cells in CbfbF/F: FIC Mice
mRNA expression profiles of CD4+CD25hi T cells
from CbfbF/F: FIC and CbfbF/+: FIC littermates
were analyzed by expression microarray (n = 3).
(A) shows fold change in expression of representa-
tive ‘‘Treg cell signature’’ genes in CD4+CD25hi
T cells from CbfbF/F: FIC mice versus CbfbF/+:
FIC littermates. *, p = 0.01; **, p = 0.03; ***, p =
0.02 (unpaired t test). (B) shows a heat map of
genes differentially expressed in CD4+CD25hi
T cells of CbfbF/F: FIC mice with statistical signifi-
cance (FDR < 0.2).
and two CNSs located in the first intron
(CNS2 and CNS3) (Kim and Leonard,
2007; Mantel et al., 2006; Tone et al.,
2008). The binding of the Runx complex
to CNS1 and CNS3 of the Foxp3 gene in
Treg cells was detected, although the
binding to CNS2 was not examined
because of unavailability of appropriate
probes for this region (Figure 5B, left).
Conventional ChIP assays revealed that
the Runx complex bound to CNS2 as
well as CNS1 and CNS3 of the Foxp3
gene in Treg cells, but not to the region
at 1 kb upstream of Zbtb7b (Th-POK)
exon Ia (UP1), which was used as a nega-
tive control locus (Setoguchi et al., 2008)
(Figure 5B, right). In CNS1 and CNS3,
but not in CNS2, there are conserved
Runx-binding consensus sites (ACCACA)
(Figure S7 and S8), suggesting that the
Runx complex might bind to CNS2 via
associating with other molecules.
Because Cbfb-deleted Treg cells
showed IL-4 hyperproduction without
overexpression of Gata3, we investigated how the Runx
complex controlled Il4 expression in Treg cells. By promoter
tiling array analysis, we could not detect the binding of the
Runx complex to the Il4 promoter region in Treg cells. However,
by coupling ChIP assay with custom tiling array for the Th2 cyto-
kine locus (200 base intervals), we found that the Runx
complex bound to the Il4 silencer in Treg cells (Figure 5C,
left). We further confirmed this binding by conventional ChIP
assays (Figure 5C, right). Thus, the Runx complex may repress
Il4 expression in Treg cells via binding to the Il4 silencer as in
naive CD4+ T cells and Th1 cells, as we and others have recently
reported (Djuretic et al., 2007; Naoe et al., 2007). ChIP and
promoter tiling array also revealed that the Runx complex
bound to the promoter region of the Ifng gene in Treg cells,
being consistent with our previous finding that Runx1 bound
to this region (Ono et al., 2007) (Figure S9). The Runx complex
also bound to the regulatory region of the Gzmb gene, which
is highly expressed in Treg cells in specific environment and is
involved in Treg cell-suppressive function (Cao et al., 2007;
Gondek et al., 2005) (Figure S10). Thus, the Runx complex binds
614 Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc.
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Figure 5. Binding of the Runx Complex to
Regulatory Regions of Foxp3 and Il4
(A) The Runx complex bound to promoter regions
of various genes in Treg cells. MACS-purified
CD4+CD25+ T cells of wild-type BALB/c mice
were subjected to ChIP with anti-Cbfb followed
by promoter tiling array. Red crosses indicate
Cbfb-bound genes.
(B) The Runx complex bound to CNSs of the Foxp3
gene in Treg cells of BALB/c mice. The binding of
the Runx complex to the Foxp3 gene locus in
double negative (DN) thymocytes and peripheral
CD4+CD25+ T cells from BALB/c mice was exam-
ined through a custom tiling array for the Foxp3
locus coupled with ChIP with Cbfb antibody (left).
The signal intensity value of an individual probe
is represented by a red dot in correspondence to
the structure of the mouse Foxp3 gene and
mouse-human VISTA homology plot of the Foxp3
gene. Red areas and blue areas in the VISTA plot
indicate highly homologous regions and the exons
of the mouse Foxp3 gene, respectively. Gray
squares in the figure of Foxp3 gene structure indi-
cate 50 untranslated regions (UTRs). The binding of
the Runx complex to CNSs of the Foxp3 gene and
the UP1 region of the Zbtb7b gene was assessed
by conventional ChIP assays (right).
(C) The Runx complex bound to the Il4 silencer in
Treg cells of BALB/c mice. The binding of the
Runx complex to the Il4 silencer in CD4+CD25+
T cells from BALB/c mice was detected with the
combination of ChIP and genome tiling array
customized for Th2 cytokine locus (left) and
conventional ChIP assays (right).to the regulatory regions of Foxp3, Il4, and other genes in Treg
cells.
RUNX1 Is Required for Optimal Regulation of FoxP3
Expression
The decreased FoxP3 expression in Cbfb-deleted Treg cells
suggests that the Runx complex is required for constitutive
FoxP3 expression in Treg cells. Because introduction of siRNA
against RUNX1 into human Treg cells efficiently repressed
RUNX1 expression (Ono et al., 2007), we examined the effect
of RUNX1 knockdown on FoxP3 expression in FoxP3-express-
ing T cell line MT-2 and in primary human CD4+CD25hi cells.
Both MT-2 cells and human Treg cells showed attenuated
expression of FoxP3 after RUNX1 siRNA transfection, indicating
a key contribution of RUNX1 to the maintenance of constitutive
FoxP3 expression (Figure 6A). Even in the presence of 100 U/ml
of IL-2, Treg cells transduced with RUNX1 siRNA still showed
lower FoxP3 expression, indicating that attenuated FoxP3
expression was independent of IL-2 supply (Figure 6B). Further,
by RT-PCR, FOXP3 mRNA expression was slightly but signifi-
cantly decreased in Cbfb-deleted Treg cells and RUNX1
siRNA-introduced MT-2 cells, indicating that the Runx complex
regulated FoxP3 expression, at least in part, at the level of tran-
scription (Figure S6 and Figure 6C). Moreover, with humanprimary naive CD4+ T cells, in which T cell receptor (TCR) stimu-
lation can induce FoxP3 expression (Mantel et al., 2006; Walker
et al., 2003), RUNX1 knockdown attenuated this activation-
induced FoxP3 expression (Figure 6D). This suggests that the
Runx complex controls not only constitutive expression of
FoxP3 in natural Treg cells but also its de novo induction in acti-
vated human CD4+ T cells.
Given that the Runx complex binds to the possible regulatory
regions of the FOXP3 gene, it may directly control FOXP3
transcription in Treg cells. We thus assessed the direct contri-
bution of the Runx complex to FOXP3 transcription by reporter
gene assays. CNS1 and CNS3 of the human FOXP3 gene
exhibited significant transactivational activities in CD4+ T cells
(Figure S11A and Supplemental Data). The mutations of
Runx-binding sites in the CNS1 and CNS3 constructs failed
to attenuate the transactivational activities observed in those
constructs (Figure S11B and Supplemental Data). However,
the Runx-site mutations in CNS1 abrogated the transactivation
of the construct in response to the stimulation (Figure 6E,
left). In contrast to CNS1, the CNS3 construct, either of wild-
type or mutant, showed no response to the stimulation (Fig-
ure 6E, right). Similar results were also observed in FoxP3-
expressing ATL-43T, a human adult T cell leukemia cell line
(Figure 6F).Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc. 615
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Figure 6. RUNX1 Was Required for Optimal
Regulation of FoxP3 Expression
(A) Expression of FoxP3 by MT-2 cells and human
primary CD4+ T cells transduced with control or
RUNX1 siRNA 3 days and 4 days after transduc-
tion, respectively. Results representative of three
experiments are shown.
(B) Effect of exogenous IL-2 on FoxP3 expression
by human primary CD4+CD25hiCD45RO naive
Treg cells and CD4+CD25hiCD45RO+ memory
Treg cells transduced with control or RUNX1
siRNA. siRNA-transduced human Treg cells were
purified 24 hr after transduction; this process
was followed by culture for 3 days in the presence
of the indicated concentrations of exogenous IL-2.
Numbers shown below the gates indicate the
mean fluorescence intensity (MFI) of FoxP3 in the
gates. Data are representative of two experiments.
(C) Relative mRNA expression of FOXP3 in MT-2
cells transduced with control or RUNX1 siRNA 24
hr and 48 hr after transduction. RNAwas extracted
from purified PI (propidium iodide)-negative viable
MT-2 cells. Results of three experiments are
shown as the mean ± SD values. *p = 0.01; **p =
0.0001 (unpaired t test).
(D) RUNX1 knockdown attenuated activation-
induced FoxP3 expression in human primary naive
CD4+ T cells. siRNA-introduced CD4+CD25
CD45RO naive T cells were stimulated with anti-
CD3 and anti-CD28 in the presence of antigen-
presenting cells for 2 or 4 days. Numbers shown
above the gates indicate the percentages of
CD4+FoxP3+ cells in CD4+ T cells. Results repre-
sentative of two experiments are shown.
(E and F) Activation of the FOXP3 CNS1 by stimu-
lation with PMA and ionomycin is dependent on
Runx-binding consensus sequences. The FOXP3
CNS1 and CNS3 constructs with or without muta-
tions in Runx sites were transfected into human
primary CD4+ T cells (E) and ATL 43T cells (F) and
cultured in medium or in medium containing PMA
and ionomycin. Results shown are the mean ± SD
of triplicates done in one experiment representa-
tive of three.Taken together, these results suggest that the Runx complex
is required for optimal regulation of FoxP3 expression.
Analyses of Runx1F/F: FIC and Runx3F/F: FIC Mice
Because both Runx1 and Runx3 were expressed in Treg cells
(Figure S12; Ono et al., 2007), we next investigated which one
played a key role for Treg cell function in vivo. We generated
Runx1F/F: FIC and Runx3F/F: FIC mice by crossing FIC mice
with Runx1-floxed or Runx3-floxed mice, respectively (Naoe
et al., 2007; Taniuchi et al., 2002). Runx1F/F: FICmice developed
histologically evident gastritis, high titers of parietal cell anti-
bodies, and hyperproduction of IgE as observed in CbfbF/F:
FIC mice, whereas IgG production was not significantly altered
(Figures 7A–7D). By contrast,Runx3F/F: FICmice did not develop
gastritis, parietal cell antibodies, or hyperproduction of IgE
(Figures 7B–7D). Runx1- but not Runx3-deleted Treg cells
showed attenuated FoxP3 expression as observed in Cbfb-
deleted Treg cells (Figure 7E). In addition, Runx1- or Runx3-
deleted Treg cells did not lose CD103 expression, whereas616 Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc.Cbfb-deleted Treg cells lost it, indicating that Runx1 and
Runx3 function redundantly in the regulation of CD103 expres-
sion (Figure 7F). Also, the finding indicates that autoimmune
phenotypes due to Cbfb deficiency in Treg cells is not attributed
to the loss of CD103 expression because CD103 expression was
not altered in autoimmune Runx1F/F: FIC mice. Our results thus
demonstrate that Runx1, but not Runx3, is indispensable for
in vivo Treg cell function but do not exclude possible functional
compensation between Runx1 and Runx3 in Treg cells.
DISCUSSION
In this study, we showed that Treg cell-specific deficiency of
Cbfb or Runx1, but not Runx3, impaired in vivo Treg cell function,
resulting in the development of autoimmune disease and hyper-
production of IgE. The immunological diseases were similar in
spectrum to those found in FoxP3 mutant or -deficient mice,
although the disease severities were much milder (Sakaguchi
et al., 2006).
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Figure 7. Development of Autoimmune
Disease and Hyperproduction of IgE in
Runx1F/F: FIC Mice, but Not in Runx3F/F:
FIC Mice
(A) Hematoxylin and eosin staining of stomach
sections of 8- to 9-week-old Runx1F/F: FIC and
Runx1F/+: FIC littermates (n = 7). Representative
photomicrographs are shown. Scale bars repre-
sent 10.0 mm.
(B) Titers of parietal cell autoantibodies in the sera
of 8- to 9-week-old Runx1F/F: FIC and Runx1F/+:
FIC littermates (n = 7) (left) and Runx3F/F: FIC and
Runx3F/+: FIC littermates (n = 7) (right) were
assessed by ELISA. Horizontal lines represent
averages from each group. *p = 0.01.
(C and D) Titers of IgE (C) and IgG (D) in the sera of
8- to 9-week-old Runx1F/F: FIC and Runx1F/+: FIC
littermates (n = 7) and Runx3F/F: FIC and Runx3F/+:
FIC littermates (n = 4) were assessed by ELISA.
Horizontal lines represent averages from each
group. **p = 0.002.
(E) Flow cytometric analysis of FoxP3 expression
by CD4+ T cells from Runx1F/F: FIC and Runx1F/+:
FIC littermates (left) and from Runx3F/F: FIC and
Runx3F/+: FIC littermates (right) at 7 weeks of
age. Results representative of three experiments
are shown.
(F) Expression of FoxP3 and the indicated mole-
cules by Runx1F/F: FIC and Runx1F/+: FIC litter-
mates and by Runx3F/F: FIC and Runx3F/+: FIC
littermates at 7 to 10 weeks of age. Results repre-
sentative of three experiments are shown.Wehave previously shown that Runx1 binds to the promoter of
the Il2 and Ifng genes and enhances IL-2 and IFN-g production in
conventional T cells. Conversely, the FoxP3-Runx1 complex,
togetherwith other transcription factors such asNFAT, represses
the expression of these cytokines and confers in vitro-suppres-
sive activity to Treg cells (Ono et al., 2007). Here, we have
provided genetic evidence that Treg cell-specific deficiency of
theRunx1-Cbfbcomplex indeed impairs in vivoTregcell function.
This indicates that Runx-dependent gene regulation is critically
required for in vivo Treg cell function. In addition, Cbfb-deficient
Treg cells transcribed Il17a and Rorgt to lesser extents than
control Treg cells, whereas Il4, Il10, and Tbx21 increased in the
former.Other studieshaveshown thatRunx1 induces theexpres-
sion of RORgt, interacts with RORgt in conventional T cells, and
regulates Il17 transcription via controlling the promoter or
enhancer regions of the Il17 gene (Zhang et al., 2008). Runx3
also acts with T-bet to activate Ifng and silence Il4 via binding
to the Ifng promoter and the Il4 silencer regions, respectively,
leading to Th1 cell-specific cytokine production (Djuretic et al.,
2007). Further, Runx1 and Runx3 interact with the Cd4 silencer
and the Zbtb7b silencer, in regulating thymocyte commitment
to the CD8+ T cell lineage by repressing the alternative cell fate
(Setoguchi et al., 2008; Taniuchi et al., 2002). Thus, the Runx
complex plays critical roles not only in T cell differentiation, in
particular CD4-CD8 lineage commitment, but also in conferringa variety of functions to T cell subsets including Th1, Th17, and
Treg cell. Further, phenotypical differences between Runx1-
and Runx3-deleted Treg cells suggest that Runx1 and Runx3
differently contribute to the differentiation and the functions of
T cell subsets. The Runx complexmay thus function as an essen-
tial core transcriptional ‘‘modifier’’ to regulate specializedeffector
functions of CD4+ T cell subsets by associating with particular
lineage-specific transcription factors including FoxP3.
Regarding the mechanism by which Treg cell function is
impaired in Cbfb- or Runx1-deficient Treg cells, a notable finding
is that Cbfb or Runx1 deficiency accompanies attenuated
expression of FoxP3 atmRNA and protein levels. Because atten-
uated FoxP3 expression can lead to loss of Treg cell-suppres-
sive function, as demonstrated by others (Wan and Flavell,
2007), reduced expression of FoxP3 might be responsible for
dysfunction of Cbfb-deleted Treg cells. For example, Nrp1 and
Pde3b, which were differentially expressed in Cbfb-deleted
Treg cells by expression microarray, could be affected by
FoxP3 hypoexpression. Other differentially expressed genes
are also possibly associated with the impaired function of
Cbfb-deleted Treg cells. They include Il4, Ltb4r1, Cd160, and
Ccr5, all of which were overexpressed in Cbfb-deleted Treg
cells. Of particular note is the hyperproduction of IL-4 by Cbfb-
deleted Treg cells. Elevated IL-4 may contribute to the impaired
Treg cell-mediated suppression in Cbfb- or Runx1-deleted TregImmunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc. 617
Immunity
Roles of Runx Complexes for Treg Cell Functioncells because it has been shown that the addition of exogenous
IL-4 renders CD4+CD25 conventional T cells resistant to in vitro
Treg cell-mediated suppression (Pace et al., 2006). We and
others have previously reported that the Runx complex
represses Il4 via binding to the Il4 silencer in naive CD4+
T cells and Th1 cells (Djuretic et al., 2007; Naoe et al., 2007).
Our observation that the Runx complex bound to the Il4 silencer
in Treg cells suggests that the complex similarly represses Il4
expression in Treg cells and that loss of Runx complex dere-
presses Il4, leading to hyperproduction of IL-4 in Cbfb-deleted
Treg cells. Nonetheless, it is also possible that reduction of
FoxP3 expression directly derepresses Il4 expression. Taken
together, our findings show that impaired suppressive function
of Cbfb-deleted Treg cells could be attributed, at least in part,
to the reduction of FoxP3 and the hyperproduction of IL-4, in
addition to the impaired formation of the Runx-Cbfb-FoxP3
complex (Ono et al., 2007).
The maintenance of constitutive FoxP3 expression in Treg
cells appears to require the Runx complex. Our observations
that the complex bound to the regulatory regions of the Foxp3
gene in Treg cells may suggest that the Runx complex would
directly upregulate FoxP3 expression. In the reporter assays,
however, Runx-binding site-dependent transactivation was
observed only under activated condition, and not under unstimu-
lated condition. This suggests that the Runx complex regulates
constitutive FoxP3 expression more than by transactivating the
FOXP3 gene. It has also been shown that RUNX1 not only is
a conventional transcriptional activator but also plays a critical
role in chromatin modifications such as histone acetylation via
interacting with histone acetyltransferases (Yoshida and
Kitabayashi, 2008). This suggests that the binding of the Runx
complex to the Foxp3 gene regulatory regions may contribute
to constitutive FoxP3 expression through epigenetic regulation.
It is also possible that the deficiency of the Runx complex may
primarily dysregulate other genes encoding molecules neces-
sary for the maintenance of FoxP3 expression in Treg cells.
These possibilities are currently under investigation.
Our results support the concept that Runx-dependent
program plays essential roles for immune homeostasis including
Treg cell-mediated immune suppression. Single-nucleotide
polymorphisms (SNPs) affecting the consensus sites for RUNX1
are associated with the genetic susceptibility to several autoim-
mune diseases including systemic lupus erythematosus, rheu-
matoid arthritis, and psoriasis (Alarcon-Riquelme, 2004; Helms
et al., 2003; Prokunina et al., 2002; Tokuhiro et al., 2003). In addi-
tion, a SNP in the RUNX1 gene itself was strongly associated
with rheumatoid arthritis (Tokuhiro et al., 2003). It is thus likely
that genetic alterations ofRUNX1may contribute to the develop-
ment of autoimmune diseases in part by means of affecting
Treg cell-mediated immune regulation. Furthermore, our study
suggests that Treg cell-specific inhibition of the activity of the
Runx1-Cbfb complex could be useful for reducing Treg cell
activity and thereby evoking effective tumor immunity.
EXPERIMENTAL PROCEDURES
Mice
C.B-17 SCID mice were purchased from CLEA Japan (Tokyo, Japan). BALB/c
mice were purchased from Japan SLC (Shizuoka, Japan). Foxp3-Ires-Cre618 Immunity 31, 609–620, October 16, 2009 ª2009 Elsevier Inc.(FIC), Runx1F, Runx3F, and CbfbF mouse strains were described previously
(Naoe et al., 2007; Taniuchi et al., 2002; Wing et al., 2008). In this paper,
a mouse described with a ‘‘FIC’’ genotype was either a FIC/Y hemizygote
male or FIC/FIC homozygote female. All mice were maintained in our animal
facility and treated in accordance with the guidelines for animal care approved
by the Institute for Frontier Medical Sciences, Kyoto University.
Antibodies
Biotinylated or FITC-, phycoerythrin (PE)-, PerCP-Cy5.5-, or allophycocyanin
(APC)-conjugated mAbs for CD4, CD8, CD25, HSA (CD24), TCRb, CD69,
CD122, CD44, CD62L, CTLA-4, Ki-67, CD127, CD103, IFN-g, IL-2, IL-4,
IL-10, and IL-17 were purchased from BD Biosciences. Biotinylated anti-
GITR (DTA1) was previously described (Shimizu et al., 2002). APC-conjugated
anti-mouse Foxp3 (FJK-16 s) was purchased from eBioscience. The following
mAbs were used for detecting human antigens: PerCP-Cy5.5-conjugated
anti-CD4 and FITC-conjugated anti-CD45RO from BD Biosciences and
biotinylated anti-human FOXP3 (236A/E7) from eBiosciences. Cbfb antibody
was generated by immunizing rabbits with peptides corresponding to the
N-terminal of Cbfb.
Histology
Gastritis and colitis were graded in a blinded fashion in accordance with the
published criteria (Asano et al., 1996; Asseman et al., 1999).
Immunoblotting
Lysates prepared from purified 5 3 103 cells were loaded and immunoblotted
with anti-Cbfb.
Identification of CbfbF and Cbfb-Deleted Allele by PCR
Equivalent amounts of genomic DNA extracted from individual lymphocyte
subset were subjected to multiplex PCR with the following primers: G2,
50-CCTCCTCATTCTAACAGGAATC-30; G3, 50-GGTTAGGAGTCATTGTGATC
AC-30; and G6, 50-CATTGGATTGGCGTTACTGG-30. CbfbF and Cbfb-deleted
alleles were identified by PCR amplification with the G3/G2 and the G3/G6
primer pair, respectively (Figure S13). The CbfbF allele-specific and the
Cbfb-deleted allele-specific amplicons were distinguished according to their
length.
ELISA
Autoantibodies specific for gastric parietal cells were detected by ELISA as
previously described (Sakaguchi et al., 1995). Serum IgG and IgE levels
were assessed by ELISA with Mouse IgG ELISA Quantitation Kit (Bethyl Labo-
ratories) and OptEIA Mouse IgE ELISA set (BD Biosciences), respectively.
Cell Sorting
Fresh mouse CD4+ T cells were isolated as previously described (Hori et al.,
2003). Then, CD4+ T cell subpopulations including CD4+CD25hi cells,
CD4+CD25 cells, and CD4+CD25-CD45RBhi cells were purified by sorting
with a cell sorter (MoFlo, Dako). In some experiments, CD4+CD25+ cells
were purified by MACS (Miltenyi Biotec).
Intracellular Cytokine Staining
Cells were stimulated for 5 hr with 20 ng/ml phorbol 12-myristate 13-acetate
(PMA) and 1 mM ionomycin in the presence of GolgiStop (BD Biosciences).
For intracellular cytokine staining, stimulated cells were stained for surface
antigens, fixed, permeabilized with BD Cytofix/Cytoperm (BD Biosciences),
and stained by anti-cytokine. For costaining of intracellular cytokine and
FoxP3, stimulated cells were stained for surface antigens, fixed, permeabilized
with Foxp3 Fixation/Permeabilization Kit (eBioscience), and finally, costained
with cytokine antibody and Foxp3 antibody.
Proliferation Assay and Suppression Assay
A total of 2 3 104 responder T cells were cultured with or without graded
numbers of suppressor cells for 3 days in the presence of 43 104 antigen-pre-
senting cells (mitomycin C-treated Thy1.2+ cell-depleted BALB/c splenocytes)
and 0.5 mg/ml CD3 antibody (145-2C11, BDBiosciences). [3H]thymidine (1 mCi/
well) was added during the last 8 hr of culture.
Immunity
Roles of Runx Complexes for Treg Cell FunctionQuantitative Real-Time RT-PCR
Total RNA was prepared from cells of interest with RNeasy Mini Kit (QIAGEN).
cDNA was synthesized from total RNA with SuperScript III reverse transcrip-
tase and oligo(dT)12-18 primer (Invitrogen). Quantitative real-time RT-PCR
was performed with the LightCycler 480 System (Roche Applied Science)
with QuantiTect SYBR Green PCR Kit (QIAGEN). Primer pairs used are listed
in Table S4. All samples were run in triplicate and the data were normalized
to Hprt mRNA expression.
Chromatin Immunoprecipitation and Tiling Array
Cells were crosslinked by the addition of one-tenth volume of fresh 11% form-
aldehyde solution for 10 min at room temperature. Cells were resuspended,
lysed in lysis buffers, and sonicated for solubilization and shearing of cross-
linked DNA. The cell extract was incubated overnight at 4C with 100 ml of
Dynal anti-rabbit IgG magnetic beads that had been preincubated with
10 mg of the Cbfb antibody. Beads were washed five times with RIPA buffer
and one time with TE containing 50 mM NaCl. Bound complexes were eluted
from the beads by heating at 65C with occasional vortexing, and crosslinking
was reversed by overnight incubation at 65C. Immunoprecipitated DNA and
whole-cell extract DNA were then purified by treatment with RNaseA,
proteinase K, and multiple phenol:chloroform:isoamyl alcohol extractions.
For conventional ChIP assays, the precipitated DNA was subjected to PCR
amplification. The primers used are as follows: FxCNS1-for, 50-AGCCCTGT
TATCTCATTGATAC-30; FxCNS1-rev, 50-GACCTCGCTCTTCTAATAATCC-30;
FxCNS2-for, 50-CCCATACCCACACTTTTGACCTCTG-30; FxCNS2-rev, 50-GC
ACTTGAAAATGAGATAACTGTTCA-30; FxCNS3-for, 50-CTGGCATCCAAGAA
AGACA-30; and FxCNS3-rev, 50-GGCTTCATCGGCAACAA-30. Primers for Il4
silencer region and for the region at 1 kb upstream of Zbtb7b (Th-POK) exon
Ia (UP1) were described previously (Naoe et al., 2007; Setoguchi et al.,
2008). For a ChIP-on-chip experiment, purified DNA was amplified twice by
LM-PCR in accordance with the manufacturer’s protocol (Agilent). We used
mouse promoter array and custommicroarrays generated by Agilent that tiled
through several loci via 60-nucleotide oligonucleotide probes. The probes,
representing the forward strand, were spaced every 200 bases and were
printed at random location on the array. Probe hybridization and scanning of
oligonucleotide array data were performed in accordance with the manufac-
turer’s protocol (Agilent). Data analyses were carried out with Feature Extrac-
tion software and ChIP Analytics software (Agilent).
RNA Interference
MT-2 cells and MACS-sorted primary human CD4+ T cells were transduced
with RUNX1 siRNA (HSS141472; Invitrogen) or Stealth RNAi negative control
GC high (Invitrogen) as previously described (Ono et al., 2007).
Expression Microarray
Total RNA was isolated with the RNeasy Micro Kit (QIAGEN). Biotinylated anti-
sense cRNA was prepared by two cycles of in vitro amplication. Biotinylated
cRNA (15 mg) was hybridized to Affymetrix GeneChip Mouse Genome 430 2.0
arrays. Data analyseswere donewith the use ofMeV (v4.2) (Saeed et al., 2003).
Induction of FoxP3 Expression in Human Naive T Cells
CD25CD45RO primary human naive T cells were negatively sorted with
MACS Pan T Cell Isolation Kit II, CD25MicroBeads, and CD45ROMicroBeads
(Miltenyi Biotec). A total of 73 106 purified naive T cells were transduced with
control or RUNX1 siRNA with a Human T Cell Nucleofector Kit (Amaxa), mixed
with 43 106 T cell-depleted syngeneic PBMCs, and then cultured in a volume
of 1 ml (12-well plates) for 24 h. Then, 7 3 105 cells were harvested and
cultured in a volume of 200 ml (96-well plates) in the presence of 0.01 mg/ml
anti-CD3 (OKT3) and 0.02 mg/ml anti-CD28 (CD28.2) for 4 days. Blood samples
were obtained from healthy adult volunteers (20–40 years old). The study was
conducted with the approval from the human ethics committee of the Institute
for Frontier Medical Sciences, Kyoto University.
Statistical analysis
Comparisons were analyzed for statistical significance by Mann-Whitney
U test, unless otherwise stated, with p < 0.05 being considered significant.ACCESSION NUMBERS
Microarray data are available from the National Center for Biotechnology Infor-
mation Gene Expression Omnibus (GEO) under accession number GSE18148.
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